Adapted problem adaptation therapy for depression in mild to moderate Alzheimer's disease dementia: A randomized controlled trial
Robert Howard(University College London), Rebecca L. Gould(The London College), Martin Wiegand(MRC Clinical Trials Unit at UCL), Malgorzata Raczek(Brighton and Sussex Medical School), Sube Banerjee(University of Nottingham), Alan Thomas(Cleveland Clinic), Esme Moniz‐Cook(University of Hull), Rowan Harwood(University of Nottingham), Charlotte Rawlinson(University College London), Peter Bentham(Queen Elizabeth Hospital Birmingham), Rachael Hunter(MRC Clinical Trials Unit at UCL), Gill Livingston(North East London NHS Foundation Trust), Philip Wilkinson(University of Oxford), Elizabeth Cort(University College London), Monica Panca(MRC Clinical Trials Unit at UCL), Chris Fox(University of California, Irvine), Vanessa Lawrence(King's College London), Gregor Russell(Bradford District Care NHS Foundation Trust), Chineze Ivenso(Aneurin Bevan University Health Board), Nicholas Freemantle(UCL Australia), Anne Downey(MRC Clinical Trials Unit at UCL)
Cited by 12
Related Papers
Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission
|The Lancet|2024|2.8k
Plastic waste associated with disease on coral reefs
|Science|2018|844
Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
|New England Journal of Medicine|2012|774
Research criteria for the diagnosis of prodromal dementia with Lewy bodies
|Neurology|2020|772
Development of a TaqMan® PCR assay with internal amplification control for the detection of African swine fever virus
|Journal of Virological Methods|2003|541